RENOTA ADKINS: Open Payments
NPI 1245419324 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,125 in 146 payments from 19 companies in 2025. Trend: 2023 $1,181 · 2024 $2,002 · 2025 $2,125
Food & beverage: $2,114Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $587 |
| Janssen Biotech, Inc. | 17 | $262 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $237 |
| Regeneron Healthcare Solutions, Inc. | 7 | $180 |
| Madrigal Pharmaceuticals | 8 | $149 |
| Phathom Pharmaceuticals, Inc. | 20 | $147 |
| Gilead Sciences, Inc. | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Ardelyx, Inc. | 4 | $66 |
| GENZYME CORPORATION | 3 | $58 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, CREON, MAVYRET, REZDIFFRA, VOQUEZNA, RINVOQ.
Industry payments across TN — which companies pay providers there.
